Roche Navigation Menu
Roche logo
  • Sign in
  • Logout
  • Search
Roche-InfoHub
  • Up
  • InfoHub
  • Search
  • Close search

						
							

Searching

    • InfoHub
    • Roche Medicines
      Roche Medicines Overview
      • Breast Cancer
      • PHESGO (pertuzumab-trastuzumab)
      • Ophthalmology
      • Vabysmo®
      • Neuroscience
      • Roche Neurology
      • Haematology
      • Other
      • Roaccutane®
    • Therapeutic Areas
      Therapeutic Areas Overview
      • Oncology
      • Breast Cancer
      • Roche Oncology Scientific Summit
      • Haematology
      • Haemophilia
      • Neuroscience
      • Roche Neurology
    • Product Safety and Professional Info
      Product Safety and Professional Info Overview
    • Clinical Trials and Patient Support
      Clinical Trials and Patient Support Overview
      • Patient Materials
    • Contact Us
      Contact Us Overview
    • About Roche
      About Roche Overview
      • Company Profile
      • History
    • InfoHub
    • Roche Medicines
      • Breast Cancer
        • PHESGO (pertuzumab-trastuzumab)
      • Ophthalmology
        • Vabysmo®
      • Neuroscience
        • Roche Neurology
      • Haematology
      • Other
        • Roaccutane®
    • Therapeutic Areas
      • Oncology
        • Breast Cancer
        • Roche Oncology Scientific Summit
      • Haematology
        • Haemophilia
      • Neuroscience
        • Roche Neurology
    • Product Safety and Professional Info
    • Clinical Trials and Patient Support
        • Patient Materials
    • Contact Us
    • About Roche
        • Company Profile
        • History
    • Sign in
    • Logout
    Close

    1 - of results for ""

    No results

    This website is intended for healthcare professionals (HCPs) only. If you are an HCP, register free to access the full content.

    Register

    You are here:

    1. Clinical Trials and Patient Support
    2. Patient Materials
    3. Ophthalmology_Patient_Materials
    4. Vabysmo Patient Guide Mauritius

    Your Guide to Vabysmo®: Audio and PDF 

    Your guide to Vabysmo Introduction

    AUDIO: Introduction

    Access the voice-over of the Vabysmo Patient Booklet - Introduction


    Chapter 3: What is DME

    AUDIO: Chapter 3

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 3


    Chapter 5: What is BRVO

    AUDIO: Chapter 5

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 5


    Chapter 8: Care after Injection

    AUDIO: Chapter 8

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 8

    Chapter 1: Important Safety Information

    AUDIO: Chapter 1

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 1


    Chapter 4: What is CRVO

    AUDIO: Chapter 4 - Part 1

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 4 - part 1


    Chapter 6: What is Vabysmo

    AUDIO: Chapter 6

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 6


    Chapter 9: Reporting Safety Information

    AUDIO: Chapter 9

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 9

    Chapter 2: What is nAMD

    AUDIO: Chapter 2

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 2


    Chapter 4: What is CRVO - Part 2

    AUDIO: Chapter 4 - Part 2

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 4 - Part 2


    Chapter 7: Treatment with Vabysmo

    AUDIO: Chapter 7

    Access the voice-over of the Vabysmo Patient Booklet - Chapter 7


    M-MU-00000028  Exp. Sept 2025

    Share
    • Share via email
    Close

    • © 2025 Roche Products (Pty) Ltd
    • 20.03.2025
    • Terms & Conditions
    • Privacy Notice
    • Cookie Policy
    • Cookie settings

    This Medical Information is intended only for healthcare professionals in South Africa. If you are not a healthcare professional please consult your healthcare provider. The products discussed herein may have different package inserts in other countries. The information in this site is intended to provide balanced, scientific and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate package insert. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. This site is not intended for adverse event reporting.